NCT02985736

Topical Scalp Psoriasis Study Evaluating Topicort Topical Spray

An Open-Label, Study Evaluating Topicort® Topical Spray 0.25% (Desoximetasone) in Patients With Scalp Psoriasis

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 20 (actual)
• Sponsor: Psoriasis Treatment Center of Central New Jersey · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

A single center, study of 20 subjects to assess 4 weeks of therapy with Topicort® twice daily BID and 12 weeks twice daily on 2 consecutive days to patients with scalp psoriasis

Detailed description

All patients will receive Topicort® twcie daily (BID) for 4 weeks. After week 4 patients will receive Topicort® twice weekly (on consecutive days) for 12 weeks, Patients will treat other body areas affected by plaque psoriasis with Topicort® during the study period (excludes face, groin, axilla)

Conditions

• Psoriasis

Interventions

Type	Name	Description
DRUG	Topicort Topical Spray

Timeline

• Start date: 2016-09-01
• Primary completion: 2017-01-27
• Completion: 2017-01-27
• First posted: 2016-12-07
• Last updated: 2024-04-09
• Results posted: 2024-04-09

Locations

1 site across 1 country: United States